The role of cancer-associated fibroblasts in the mechanical remodelling of the extracellular matrix and the development of drug resistance
Year: 2025
Type: dissertation
Abstract: More than one in four people develop a cancer before the age of 75 in Finland and ca. one in 10 people dies from cancer, typically from lung, colorectal or prostate cancer. In majority of cases, these cancer types form a solid tumour into tissue, where cancer-associated fibroblasts (CAFs) have an integral role. The purpose of this thesis is to research current literature on the role of CAFs in the mechanical remodelling of the extracellular matrix (ECM), connection between the mechanical remodelling and the development of drug resistance and the current state of CAF and the ECM remodelling targeting therapeutical strategies. CAFs are a heterogenous group of cells with various origins, functions and phenotypes. They produce various structural biomolecules, such as proteins collagen and fibronectin, into the ECM, increasing its stiffness by elevating its density. The denser and stiffer ECM promotes tumour progression and CAF activation. CAFs also secrete cytokines, chemokines and growth factors, implementing numerous functions. The reviewed literature extensively demonstrates CAFs' capability in mechanical remodelling of the ECM and, that the remodelling develops drug resistance. CAFs remodel the ECM by accelerating the production of collagen, fibronectin and hyaluronic acid, elevating its density and making it stiffer. Furthermore, CAFs align collagen and fibronectin fibre forming pathways for cancer cells to enhance invasiveness and increase collagen cross-linking creating strong network-like structures. The remodelling improves cancer cells’ drug resistance. Collagen cross-linking and the stiff ECM create physical barriers and suppress tumour perfusion, which impedes drug delivery. The elevated density also increases cell-cell and cell-ECM contact promoting cell adhesion-mediated drug resistance and secretion of chemoresistance enhancing growth factors. The stiff and dense ECM elevates interstitial pressure and mechanical stress, which activates signalling pathways preventing drug induced apoptosis. The current therapeutical strategies targeting CAFs and the ECM remodelling focuses on three objectives: depletion, inhibition and reprogramming. Depletion strategies target specific cell membrane markers and deplete these cells. Inhibition strategies prevent CAFs from implementing cancer progression promoting functions by inhibiting the numerous factors CAFs secrete into the ECM. Reprogramming strategies focuses on deactivating or reprogramming CAFs into cancer restrictive phenotype or normalizing the remodelled ECM to improve chemosensitivity. Literature indicates that currently the most effective therapeutical strategies are focusing on inhibition. Proposed future research directions are to complement the understanding of CAF heterogeneity and further develop the replication of tumour microenvironment outside the human body to improve the translation of preclinical results into clinical trials.
Source: Aaltodoc (Aalto University)
Author: Karjalainen, Tuomas
Institution: Aalto University
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Keywords: cancer-associated fibroblasts, extracellular matrix remodeling, extracellular matrix stiffness, drug resistance, chemoresistance, collagen cross-linking, hyaluronic acid, tumor microenvironment, interstitial fluid pressure, ECM-targeted therapy, lung cancer, colorectal cancer, prostate cancer, tumor invasion
Open Access status: green
OpenAlex ID: W7083222974
